— Know what they know.
Not Investment Advice

600062.SS SHH

China Resources Double-Crane Pharmaceutical Co.,Ltd.
1W: +0.9% 1M: +1.0% 3M: -3.0% YTD: -13.3% 1Y: -19.1% 3Y: +1.2% 5Y: +58.6%
¥16.24 ($2.42)
+0.32 (+2.01%)
 
SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · ¥16.9B mcap · 399M float · 2.00% daily turnover

📊 Key Metrics

TTM
¥11B
Revenue
-1.4% YoY
¥2B
Net Income
+3.9% YoY
¥893M
Free Cash Flow
+0.6% YoY
54.5%
Gross Margin
16.3%
Op. Margin
16.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE13.9%
ROA9.2%
ROIC13.9%

Valuation

P/E10.3
P/B1.4
EV/EBITDA6.2

Leverage

Debt/Equity0.10
Current Ratio2.16
Interest Cov.57.9x

Quality Scores

Piotroski F4/9
Altman Z3.94
Beneish M-2.25

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms